Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

$5.50
VAT Exempt
In stock
SKU
JTCM-1390

To read the full abstract subscribe to the JCM online archive

Based on current trends, chronic obstructive pulmonary disease (COPD) is predicted to become the fifth top health burden in the world by 2020. This study looked at the effect ...
More Information
Author Liu Miao et al
Write Your Own Review
You're reviewing:Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.